Prevalence of complementary medicine use in a phase 1 clinical trials program-Reference-Cited by-同舟云学术

Prevalence of complementary medicine use in a phase 1 clinical trials program

Published:2011-04-28 Issue:22 Volume:117 Page:5142-5150
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Naing Aung,Stephen Saneese K.,Frenkel Moshe,Chandhasin Chandtip,Hong David S.,Lei Xiudong,Falchook Gerald,Wheler Jennifer J.,Fu Siqing,Kurzrock Razelle

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference19 articles.

1. http://nccam.nih.gov/health/whatiscam/

2. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies;Navo;J Clin Oncol.,2004

3. The role of complementary and alternative medicine;Ernst;Lancet Oncol.,2000

4. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology;Richardson;J Clin Oncol.,2000

5. The use of complementary therapy by men with prostate cancer in the UK;Wilkinson;Eur J Cancer Care (Engl).,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin inhibits chronic stress-mediated progression of triple-negative breast cancer by blocking β2-AR/ERK1/2 pathway;Biomedicine & Pharmacotherapy;2024-08

2. Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial;Breast Cancer: Targets and Therapy;2024-05

3. Patient Trust Through the Lens of Integrative Oncology;Psychiatry Update;2024

4. Assessing the quality of complementary, alternative, and integrative medicine website information for cancer: A cross-sectional survey and analysis;European Journal of Integrative Medicine;2023-12

5. Chronic stress in solid tumor development: from mechanisms to interventions;Journal of Biomedical Science;2023-01-28